Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabricio G Sousa

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|December 5, 2015
rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in RAugustin Luna, Vinodh N Rajapakse, Fabricio G Sousa, et al.
Carcinogenesis|March 21, 2012
PARPs and the DNA damage responseFabricio G Sousa, Renata Matuo, Daniele G Soares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing SarcomaSai-Wen Tang, Sven Bilke, Liang Cao, et al.
DNA Repair|March 12, 2015
Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activityFabricio G Sousa, Renata Matuo, Sai-Wen Tang, et al.
Molecular Cancer Therapeutics|May 20, 2016
Chromatin Regulators as a Guide for Cancer Treatment ChoiceZachary A Gurard-Levin, Laurence O W Wilson, Vera Pancaldi, et al.
Iscience|December 17, 2018
CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell LinesVinodh N Rajapakse, Augustin Luna, Mihoko Yamade, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|December 5, 2015
rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in RAugustin Luna, Vinodh N Rajapakse, Fabricio G Sousa, et al.
Carcinogenesis|March 21, 2012
PARPs and the DNA damage responseFabricio G Sousa, Renata Matuo, Daniele G Soares, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing SarcomaSai-Wen Tang, Sven Bilke, Liang Cao, et al.
DNA Repair|March 12, 2015
Alterations of DNA repair genes in the NCI-60 cell lines and their predictive value for anticancer drug activityFabricio G Sousa, Renata Matuo, Sai-Wen Tang, et al.
Molecular Cancer Therapeutics|May 20, 2016
Chromatin Regulators as a Guide for Cancer Treatment ChoiceZachary A Gurard-Levin, Laurence O W Wilson, Vera Pancaldi, et al.
Iscience|December 17, 2018
CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell LinesVinodh N Rajapakse, Augustin Luna, Mihoko Yamade, et al.
Pageof 1